Trexquant Investment LP Protagonist Therapeutics, Inc Transaction History

Trexquant Investment LP

$6.33 Billion
Q2 2024

A detailed history of Trexquant Investment LP transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Trexquant Investment LP holds 80,614 shares of PTGX stock, worth $3.84 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

80,614

Previous 102,379 21.26%

Holding current value

$3.84 Million

Previous $2.96 Million 5.67%

% of portfolio

0.04%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$24.66 - $34.8 $536,724 - $757,421	-21,765 Reduced 21.26%	80,614 $2.79 Million
Q1 2024 May 14, 2024	BUY	$21.79 - $32.15 $2.23 Million - $3.29 Million	102,379 New	102,379 $2.96 Million
Q2 2023 Aug 11, 2023	BUY	$18.02 - $29.36 $205,662 - $335,085	11,413 New	11,413 $315,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $11.71 $176,229 - $262,549	22,421 New	22,421 $189,000
Q2 2022 Aug 11, 2022	SELL	$7.06 - $25.52 $69,152 - $249,968	-9,795 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$23.34 - $36.08 $228,615 - $353,403	9,795 New	9,795 $232,000
Q2 2021 Aug 12, 2021	SELL	$25.57 - $44.88 $269,047 - $472,227	-10,522 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$19.02 - $31.15 $143,639 - $235,244	-7,552 Reduced 41.78%	10,522 $273,000
Q4 2020 Feb 11, 2021	BUY	$18.49 - $25.13 $334,188 - $454,199	18,074 New	18,074 $364,000
Q3 2020 Nov 06, 2020	SELL	$15.19 - $22.4 $162,639 - $239,836	-10,707 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$6.19 - $18.84 $60,501 - $184,142	-9,774 Reduced 47.72%	10,707 $189,000
Q1 2020 May 08, 2020	BUY	$5.4 - $9.22 $110,597 - $188,834	20,481 New	20,481 $145,000
Q1 2019 May 13, 2019	SELL	$6.5 - $13.77 $119,060 - $252,225	-18,317 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$6.3 - $10.44 $70,956 - $117,585	-11,263 Reduced 38.08%	18,317 $123,000
Q3 2018 Nov 09, 2018	BUY	$6.82 - $11.26 $201,735 - $333,070	29,580 New	29,580 $304,000
Q2 2018 Aug 07, 2018	SELL	$5.99 - $9.1 $134,810 - $204,804	-22,506 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$8.46 - $23.08 $45,684 - $124,631	5,400 Added 31.57%	22,506 $193,000
Q4 2017 Feb 09, 2018	BUY	$14.47 - $20.8 $247,523 - $355,804	17,106	17,106 $356,000

Others Institutions Holding PTGX

# of Institutions

212

Shares Held

59.1M

Call Options Held

19K

Put Options Held

107K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.34B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Protagonist Therapeutics, Inc Transaction History